Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Cancer (no longer under consideration since Feb 06, 2025)

Date Submitted: Nov 6, 2024
Open Peer Review Period: Nov 20, 2024 - Jan 15, 2025
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Stain Augmentation via Stain Separation Enhances Classification and Segmentation in H&E Breast Cancer Histopathology: Development and Validation Study

  • Ho Heon Kim; 
  • Won Chan Jeong; 
  • Youngjin Park; 
  • Young Sin Ko

ABSTRACT

Background:

Digitization of histopathological samples into whole slide images (WSIs) with hematoxylin and eosin (H&E) staining enables deep-learning applications for cancer detection. However, the performance of deep learning models in digital pathology is often compromised by variations in the staining protocols, scanner types, and biological differences across samples. To address this issue, a stain augmentation (SA) method was proposed, which learns the color distribution of a training dataset and generates new images using this distribution. Despite these advantages, overreliance on a single or homogeneous domain can generate similarly stained images, limiting the robustness of the model.

Objective:

In this study, we developed and validated an SA method based on stain separation that improved classification performance in H&E-stained breast cancer tissues, even when data are obtained from a single domain.

Methods:

The augmentation method was validated in both classification and segmentation tasks: 1) five domains in Camelyon17 for classification and 2) three domains in cross-organ and cross-scanner adenocarcinoma segmentation (COSAS) for segmentation, which separated the stain vector and stain density from H&E images and perturbed them by considering the counterstaining characteristics of H&E staining. The predictive model was trained for each domain and assessed in the other domains.

Results:

We obtained 348,091 and 6,989 patch images from the Camelyon17 and COSAS datasets, respectively, for image classification and segmentation tasks. Significant differences were observed in the mean color channel values across all domains in both the hue-saturation-value (HSV) and CIELAB color spaces (P < 0.05). The augmentation approach improved performance over the baseline model, yielding area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPRC) values of 0.949 (+0.142) and 0.831 (+0.306), respectively, compared to the baseline model’s values of 0.807 and 0.525. Combining this technique with RandStainNA further enhanced performance, achieving AUROC and AUPRC values of 0.955 (+0.019) and 0.857 (+0.048), compared to RandStainNA alone (0.936 and 0.808). Additionally, the feature extractor trained with this augmentation demonstrated reduced prediction error for color-jittered images compared to other methods, with an average L2 distance of 0.092 and cosine similarity of 0.992. Under substantial color variation, the mixed approach maintained robust classification performance, achieving AUROC and AUPRC values of 0.887 (+0.054) and 0.758 (+0.081), outperforming RandStainNA (0.833 and 0.677) and the augmentation approach alone (0.852 and 0.705)

Conclusions:

Stain augmentation using stain separation enhanced the performance of deep learning without data dependence in the segmentation and classification of heterogeneous H&E-stained breast cancer images.


 Citation

Please cite as:

Kim HH, Jeong WC, Park Y, Ko YS

Stain Augmentation via Stain Separation Enhances Classification and Segmentation in H&E Breast Cancer Histopathology: Development and Validation Study

JMIR Preprints. 06/11/2024:68446

DOI: 10.2196/preprints.68446

URL: https://preprints.jmir.org/preprint/68446

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.